Levonorgestrel/meloxicam - InnovaGyn
Alternative Names: IG-002 - InnovaGyn; Meloxicam/levonorgestrel - InnovaGynLatest Information Update: 09 Apr 2024
At a glance
- Originator InnovaGyn
- Class 2 ring heterocyclic compounds; Amides; Analgesics; Anti-inflammatories; Antipyretics; Antirheumatics; Hormonal contraceptives; Hormonal replacements; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Norpregnanes; Oral contraceptives; Progesterone congeners; Small molecules; Thiazines; Thiazoles
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Pregnancy
Most Recent Events
- 10 Dec 2023 InnovaGyn initiates a phase II trial for Pregnancy (Prevention) in the US (NCT06306131)
- 28 Jun 2022 Phase-II clinical trials in Pregnancy (Prevention, In adults) in USA (PO) (NCT05695352)